http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 19 Nov 2024 04:47:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Epitomee%27s+Drug-Free+Capsule+Helps+Patients+Shed+Pounds%3A+RESET+Study+Results+presented+at+ObesityWeek%C2%AE+2024/24000994.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/il..caerea" idsrc="xmltag.org" >CAESAREA, Israel</location></span>, <span class="legendSpanClass"><chron>Nov. 19, 2024</chron></span> /PRNewswire/ -- Epitomee<span> <span>Medical Ltd.</span> (</span>TASE<span>: </span>EPIT<span>) announces that significant results from its </span><b>RESET study</b><span> on a novel oral </span>hydrogel<span> capsule for weight loss were presented at </span><b>ObesityWeek® 2024</b><span>. The prestigious event, organized by </span><b><span>The Obesity Society</span> (TOS)</b><span>, took place from <chron>November 2-6, 2024</chron>, in <location value="LU/us.tx.sanant" idsrc="xmltag.org" >San Antonio, Texas</location>.</span></p> <div id="prni_dvprnejpgdd9cleft" dir="ltr" style="width: 100%; text-align: left;"><img id="prnejpgdd9cleft" title="Epitomee Medical Logo" src="https://mma.prnewswire.com/media/2506356/Epitomee_Medical_Logo.jpg" alt="Epitomee Medical Logo" align="middle" /></div><p> </p> <p>The oral presentation, delivered by <b>Professor <person>Jamy D. Ard</person></b> <b>MD</b> of <span>Wake Forest University School of Medicine</span>, highlighted the results of a randomized, double-blind, placebo-controlled http://www.streetinsider.com/Press+Releases/Epitomee%27s+Drug-Free+Capsule+Helps+Patients+Shed+Pounds%3A+RESET+Study+Results+presented+at+ObesityWeek%C2%AE+2024/24000994.html Tue, 19 Nov 2024 04:47:00 -0400 EPIT O.13786802 http://www.streetinsider.com/Press+Releases/Epitomee%27s+Drug-Free+Capsule+Helps+Patients+Shed+Pounds%3A+RESET+Study+Results+presented+at+ObesityWeek%C2%AE+2024/24000994.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/il..caerea" idsrc="xmltag.org" >CAESAREA, Israel</location></span>, <span class="legendSpanClass"><chron>Nov. 19, 2024</chron></span> /PRNewswire/ -- Epitomee<span> <span>Medical Ltd.</span> (</span>TASE<span>: </span>EPIT<span>) announces that significant results from its </span><b>RESET study</b><span> on a novel oral </span>hydrogel<span> capsule for weight loss were presented at </span><b>ObesityWeek® 2024</b><span>. The prestigious event, organized by </span><b><span>The Obesity Society</span> (TOS)</b><span>, took place from <chron>November 2-6, 2024</chron>, in <location value="LU/us.tx.sanant" idsrc="xmltag.org" >San Antonio, Texas</location>.</span></p> <div id="prni_dvprnejpgdd9cleft" dir="ltr" style="width: 100%; text-align: left;"><img id="prnejpgdd9cleft" title="Epitomee Medical Logo" src="https://mma.prnewswire.com/media/2506356/Epitomee_Medical_Logo.jpg" alt="Epitomee Medical Logo" align="middle" /></div><p> </p> <p>The oral presentation, delivered by <b>Professor <person>Jamy D. Ard</person></b> <b>MD</b> of <span>Wake Forest University School of Medicine</span>, highlighted the results of a randomized, double-blind, placebo-controlled http://www.streetinsider.com/Press+Releases/Epitomee%27s+Drug-Free+Capsule+Helps+Patients+Shed+Pounds%3A+RESET+Study+Results+presented+at+ObesityWeek%C2%AE+2024/24000994.html Tue, 19 Nov 2024 04:47:00 -0400 EPIT O.13786802 http://www.streetinsider.com/PRNewswire/Epitomee%27s+Drug-Free+Capsule+Helps+Patients+Shed+Pounds%3A+RESET+Study+Results+presented+at+ObesityWeek%C2%AE+2024/24000994.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/il..caerea" idsrc="xmltag.org" >CAESAREA, Israel</location></span>, <span class="legendSpanClass"><chron>Nov. 19, 2024</chron></span> /PRNewswire/ -- Epitomee<span> <span>Medical Ltd.</span> (</span>TASE<span>: </span>EPIT<span>) announces that significant results from its </span><b>RESET study</b><span> on a novel oral </span>hydrogel<span> capsule for weight loss were presented at </span><b>ObesityWeek® 2024</b><span>. The prestigious event, organized by </span><b><span>The Obesity Society</span> (TOS)</b><span>, took place from <chron>November 2-6, 2024</chron>, in <location value="LU/us.tx.sanant" idsrc="xmltag.org" >San Antonio, Texas</location>.</span></p> <div id="prni_dvprnejpgdd9cleft" dir="ltr" style="width: 100%; text-align: left;"><img id="prnejpgdd9cleft" title="Epitomee Medical Logo" src="https://mma.prnewswire.com/media/2506356/Epitomee_Medical_Logo.jpg" alt="Epitomee Medical Logo" align="middle" /></div><p> </p> <p>The oral presentation, delivered by <b>Professor <person>Jamy D. Ard</person></b> <b>MD</b> of <span>Wake Forest University School of Medicine</span>, highlighted the results of a randomized, double-blind, placebo-controlled http://www.streetinsider.com/PRNewswire/Epitomee%27s+Drug-Free+Capsule+Helps+Patients+Shed+Pounds%3A+RESET+Study+Results+presented+at+ObesityWeek%C2%AE+2024/24000994.html Tue, 19 Nov 2024 04:47:00 -0400 EPIT O.13786802 http://www.streetinsider.com/PRNewswire/Epitomee%27s+Drug-Free+Capsule+Helps+Patients+Shed+Pounds%3A+RESET+Study+Results+presented+at+ObesityWeek%C2%AE+2024/24000994.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/il..caerea" idsrc="xmltag.org" >CAESAREA, Israel</location></span>, <span class="legendSpanClass"><chron>Nov. 19, 2024</chron></span> /PRNewswire/ -- Epitomee<span> <span>Medical Ltd.</span> (</span>TASE<span>: </span>EPIT<span>) announces that significant results from its </span><b>RESET study</b><span> on a novel oral </span>hydrogel<span> capsule for weight loss were presented at </span><b>ObesityWeek® 2024</b><span>. The prestigious event, organized by </span><b><span>The Obesity Society</span> (TOS)</b><span>, took place from <chron>November 2-6, 2024</chron>, in <location value="LU/us.tx.sanant" idsrc="xmltag.org" >San Antonio, Texas</location>.</span></p> <div id="prni_dvprnejpgdd9cleft" dir="ltr" style="width: 100%; text-align: left;"><img id="prnejpgdd9cleft" title="Epitomee Medical Logo" src="https://mma.prnewswire.com/media/2506356/Epitomee_Medical_Logo.jpg" alt="Epitomee Medical Logo" align="middle" /></div><p> </p> <p>The oral presentation, delivered by <b>Professor <person>Jamy D. Ard</person></b> <b>MD</b> of <span>Wake Forest University School of Medicine</span>, highlighted the results of a randomized, double-blind, placebo-controlled http://www.streetinsider.com/PRNewswire/Epitomee%27s+Drug-Free+Capsule+Helps+Patients+Shed+Pounds%3A+RESET+Study+Results+presented+at+ObesityWeek%C2%AE+2024/24000994.html Tue, 19 Nov 2024 04:47:00 -0400 EPIT O.13786802 http://www.streetinsider.com/Press+Releases/Epitomee+Medical+to+Present+the+Epitomee+Breakthrough+Oral+Delivery+Platform+at+PODD+2024+Conference/23834337.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/il..caerea" idsrc="xmltag.org" >CAESAREA, Israel</location></span>, <span class="legendSpanClass"><chron>Oct. 15, 2024</chron></span> /PRNewswire/ --<b> <span value="TelAviv:EPIT" idsrc="xmltag.org" >Epitomee Medical Ltd.</span> </b>(TASE: EPIT) announces today that the company leadership intends to present Epitomee's Oral Delivery of Biologics Platform at the <b>14th Annual <span>PODD Conference</span></b> - Partnership Opportunities in Drug Delivery, taking place in <location value="LU/us.ma.boston" idsrc="xmltag.org" >Boston, MA</location>, <chron>October 28-29, 2024</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Epitomee+Medical+to+Present+the+Epitomee+Breakthrough+Oral+Delivery+Platform+at+PODD+2024+Conference/23834337.html Tue, 15 Oct 2024 07:42:00 -0400 EPIT O.13786802 http://www.streetinsider.com/Press+Releases/Epitomee+Medical+to+Present+the+Epitomee+Breakthrough+Oral+Delivery+Platform+at+PODD+2024+Conference/23834337.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/il..caerea" idsrc="xmltag.org" >CAESAREA, Israel</location></span>, <span class="legendSpanClass"><chron>Oct. 15, 2024</chron></span> /PRNewswire/ --<b> <span value="TelAviv:EPIT" idsrc="xmltag.org" >Epitomee Medical Ltd.</span> </b>(TASE: EPIT) announces today that the company leadership intends to present Epitomee's Oral Delivery of Biologics Platform at the <b>14th Annual <span>PODD Conference</span></b> - Partnership Opportunities in Drug Delivery, taking place in <location value="LU/us.ma.boston" idsrc="xmltag.org" >Boston, MA</location>, <chron>October 28-29, 2024</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Epitomee+Medical+to+Present+the+Epitomee+Breakthrough+Oral+Delivery+Platform+at+PODD+2024+Conference/23834337.html Tue, 15 Oct 2024 07:42:00 -0400 EPIT O.13786802 http://www.streetinsider.com/PRNewswire/Epitomee+Medical+to+Present+the+Epitomee+Breakthrough+Oral+Delivery+Platform+at+PODD+2024+Conference/23834337.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/il..caerea" idsrc="xmltag.org" >CAESAREA, Israel</location></span>, <span class="legendSpanClass"><chron>Oct. 15, 2024</chron></span> /PRNewswire/ --<b> <span value="TelAviv:EPIT" idsrc="xmltag.org" >Epitomee Medical Ltd.</span> </b>(TASE: EPIT) announces today that the company leadership intends to present Epitomee's Oral Delivery of Biologics Platform at the <b>14th Annual <span>PODD Conference</span></b> - Partnership Opportunities in Drug Delivery, taking place in <location value="LU/us.ma.boston" idsrc="xmltag.org" >Boston, MA</location>, <chron>October 28-29, 2024</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/Epitomee+Medical+to+Present+the+Epitomee+Breakthrough+Oral+Delivery+Platform+at+PODD+2024+Conference/23834337.html Tue, 15 Oct 2024 07:42:00 -0400 EPIT O.13786802 http://www.streetinsider.com/PRNewswire/Epitomee+Medical+to+Present+the+Epitomee+Breakthrough+Oral+Delivery+Platform+at+PODD+2024+Conference/23834337.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/il..caerea" idsrc="xmltag.org" >CAESAREA, Israel</location></span>, <span class="legendSpanClass"><chron>Oct. 15, 2024</chron></span> /PRNewswire/ --<b> <span value="TelAviv:EPIT" idsrc="xmltag.org" >Epitomee Medical Ltd.</span> </b>(TASE: EPIT) announces today that the company leadership intends to present Epitomee's Oral Delivery of Biologics Platform at the <b>14th Annual <span>PODD Conference</span></b> - Partnership Opportunities in Drug Delivery, taking place in <location value="LU/us.ma.boston" idsrc="xmltag.org" >Boston, MA</location>, <chron>October 28-29, 2024</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/Epitomee+Medical+to+Present+the+Epitomee+Breakthrough+Oral+Delivery+Platform+at+PODD+2024+Conference/23834337.html Tue, 15 Oct 2024 07:42:00 -0400 EPIT O.13786802 http://www.streetinsider.com/Press+Releases/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html <div class="xn-content"> <p><b>Epitomee's Ingestible Capsule, Offers a Safe and Effective Prescription Solution for Adults with BMI of 25-40 looking for Alternative Drug Free Solutions for Their Weight Management Needs alongside diet and exercise.</b></p> <p><span class="legendSpanClass"><location value="LU/il..caerea" idsrc="xmltag.org" >CAESAREA, Israel</location></span>, <span class="legendSpanClass"><chron>Sept. 16, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://epitomeemedical.com/" target="_blank" rel="nofollow"><span value="TelAviv:EPIT" idsrc="xmltag.org" >Epitomee Medical Ltd.</span></a> (TASE: EPIT), announced that the <span>United States Food and Drug Administration</span> (FDA) has officially cleared the Epitomee® Capsule, a cutting-edge ingestible medical device designed to support weight management in adults with a Body Mass Index (BMI) of 25–40 kg/m² alongside diet and exercise. This novel, drug-free treatment http://www.streetinsider.com/Press+Releases/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html Mon, 16 Sep 2024 11:01:00 -0400 A.31792002 A.36719721 ELOS EPIT O.01155462 O.13786802 O.13804369 http://www.streetinsider.com/Press+Releases/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html <div class="xn-content"> <p><b>Epitomee's Ingestible Capsule, Offers a Safe and Effective Prescription Solution for Adults with BMI of 25-40 looking for Alternative Drug Free Solutions for Their Weight Management Needs alongside diet and exercise.</b></p> <p><span class="legendSpanClass"><location value="LU/il..caerea" idsrc="xmltag.org" >CAESAREA, Israel</location></span>, <span class="legendSpanClass"><chron>Sept. 16, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://epitomeemedical.com/" target="_blank" rel="nofollow"><span value="TelAviv:EPIT" idsrc="xmltag.org" >Epitomee Medical Ltd.</span></a> (TASE: EPIT), announced that the <span>United States Food and Drug Administration</span> (FDA) has officially cleared the Epitomee® Capsule, a cutting-edge ingestible medical device designed to support weight management in adults with a Body Mass Index (BMI) of 25–40 kg/m² alongside diet and exercise. This novel, drug-free treatment http://www.streetinsider.com/Press+Releases/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html Mon, 16 Sep 2024 11:01:00 -0400 A.31792002 A.36719721 ELOS EPIT O.01155462 O.13786802 O.13804369 http://www.streetinsider.com/Press+Releases/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html <div class="xn-content"> <p><b>Epitomee's Ingestible Capsule, Offers a Safe and Effective Prescription Solution for Adults with BMI of 25-40 looking for Alternative Drug Free Solutions for Their Weight Management Needs alongside diet and exercise.</b></p> <p><span class="legendSpanClass"><location value="LU/il..caerea" idsrc="xmltag.org" >CAESAREA, Israel</location></span>, <span class="legendSpanClass"><chron>Sept. 16, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://epitomeemedical.com/" target="_blank" rel="nofollow"><span value="TelAviv:EPIT" idsrc="xmltag.org" >Epitomee Medical Ltd.</span></a> (TASE: EPIT), announced that the <span>United States Food and Drug Administration</span> (FDA) has officially cleared the Epitomee® Capsule, a cutting-edge ingestible medical device designed to support weight management in adults with a Body Mass Index (BMI) of 25–40 kg/m² alongside diet and exercise. This novel, drug-free treatment http://www.streetinsider.com/Press+Releases/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html Mon, 16 Sep 2024 11:01:00 -0400 A.31792002 A.36719721 ELOS EPIT O.01155462 O.13786802 O.13804369 http://www.streetinsider.com/Press+Releases/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html <div class="xn-content"> <p><b>Epitomee's Ingestible Capsule, Offers a Safe and Effective Prescription Solution for Adults with BMI of 25-40 looking for Alternative Drug Free Solutions for Their Weight Management Needs alongside diet and exercise.</b></p> <p><span class="legendSpanClass"><location value="LU/il..caerea" idsrc="xmltag.org" >CAESAREA, Israel</location></span>, <span class="legendSpanClass"><chron>Sept. 16, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://epitomeemedical.com/" target="_blank" rel="nofollow"><span value="TelAviv:EPIT" idsrc="xmltag.org" >Epitomee Medical Ltd.</span></a> (TASE: EPIT), announced that the <span>United States Food and Drug Administration</span> (FDA) has officially cleared the Epitomee® Capsule, a cutting-edge ingestible medical device designed to support weight management in adults with a Body Mass Index (BMI) of 25–40 kg/m² alongside diet and exercise. This novel, drug-free treatment http://www.streetinsider.com/Press+Releases/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html Mon, 16 Sep 2024 11:01:00 -0400 A.31792002 A.36719721 ELOS EPIT O.01155462 O.13786802 O.13804369 http://www.streetinsider.com/Press+Releases/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html <div class="xn-content"> <p><b>Epitomee's Ingestible Capsule, Offers a Safe and Effective Prescription Solution for Adults with BMI of 25-40 looking for Alternative Drug Free Solutions for Their Weight Management Needs alongside diet and exercise.</b></p> <p><span class="legendSpanClass"><location value="LU/il..caerea" idsrc="xmltag.org" >CAESAREA, Israel</location></span>, <span class="legendSpanClass"><chron>Sept. 16, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://epitomeemedical.com/" target="_blank" rel="nofollow"><span value="TelAviv:EPIT" idsrc="xmltag.org" >Epitomee Medical Ltd.</span></a> (TASE: EPIT), announced that the <span>United States Food and Drug Administration</span> (FDA) has officially cleared the Epitomee® Capsule, a cutting-edge ingestible medical device designed to support weight management in adults with a Body Mass Index (BMI) of 25–40 kg/m² alongside diet and exercise. This novel, drug-free treatment http://www.streetinsider.com/Press+Releases/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html Mon, 16 Sep 2024 11:01:00 -0400 A.31792002 A.36719721 ELOS EPIT O.01155462 O.13786802 O.13804369 http://www.streetinsider.com/Press+Releases/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html <div class="xn-content"> <p><b>Epitomee's Ingestible Capsule, Offers a Safe and Effective Prescription Solution for Adults with BMI of 25-40 looking for Alternative Drug Free Solutions for Their Weight Management Needs alongside diet and exercise.</b></p> <p><span class="legendSpanClass"><location value="LU/il..caerea" idsrc="xmltag.org" >CAESAREA, Israel</location></span>, <span class="legendSpanClass"><chron>Sept. 16, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://epitomeemedical.com/" target="_blank" rel="nofollow"><span value="TelAviv:EPIT" idsrc="xmltag.org" >Epitomee Medical Ltd.</span></a> (TASE: EPIT), announced that the <span>United States Food and Drug Administration</span> (FDA) has officially cleared the Epitomee® Capsule, a cutting-edge ingestible medical device designed to support weight management in adults with a Body Mass Index (BMI) of 25–40 kg/m² alongside diet and exercise. This novel, drug-free treatment http://www.streetinsider.com/Press+Releases/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html Mon, 16 Sep 2024 11:01:00 -0400 A.31792002 A.36719721 ELOS EPIT O.01155462 O.13786802 O.13804369 http://www.streetinsider.com/Press+Releases/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html <div class="xn-content"> <p><b>Epitomee's Ingestible Capsule, Offers a Safe and Effective Prescription Solution for Adults with BMI of 25-40 looking for Alternative Drug Free Solutions for Their Weight Management Needs alongside diet and exercise.</b></p> <p><span class="legendSpanClass"><location value="LU/il..caerea" idsrc="xmltag.org" >CAESAREA, Israel</location></span>, <span class="legendSpanClass"><chron>Sept. 16, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://epitomeemedical.com/" target="_blank" rel="nofollow"><span value="TelAviv:EPIT" idsrc="xmltag.org" >Epitomee Medical Ltd.</span></a> (TASE: EPIT), announced that the <span>United States Food and Drug Administration</span> (FDA) has officially cleared the Epitomee® Capsule, a cutting-edge ingestible medical device designed to support weight management in adults with a Body Mass Index (BMI) of 25–40 kg/m² alongside diet and exercise. This novel, drug-free treatment http://www.streetinsider.com/Press+Releases/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html Mon, 16 Sep 2024 11:01:00 -0400 A.31792002 A.36719721 ELOS EPIT O.01155462 O.13786802 O.13804369 http://www.streetinsider.com/PRNewswire/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html <div class="xn-content"> <p><b>Epitomee's Ingestible Capsule, Offers a Safe and Effective Prescription Solution for Adults with BMI of 25-40 looking for Alternative Drug Free Solutions for Their Weight Management Needs alongside diet and exercise.</b></p> <p><span class="legendSpanClass"><location value="LU/il..caerea" idsrc="xmltag.org" >CAESAREA, Israel</location></span>, <span class="legendSpanClass"><chron>Sept. 16, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://epitomeemedical.com/" target="_blank" rel="nofollow"><span value="TelAviv:EPIT" idsrc="xmltag.org" >Epitomee Medical Ltd.</span></a> (TASE: EPIT), announced that the <span>United States Food and Drug Administration</span> (FDA) has officially cleared the Epitomee® Capsule, a cutting-edge ingestible medical device designed to support weight management in adults with a Body Mass Index (BMI) of 25–40 kg/m² alongside diet and exercise. This novel, drug-free treatment http://www.streetinsider.com/PRNewswire/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html Mon, 16 Sep 2024 11:01:00 -0400 A.31792002 A.36719721 ELOS EPIT O.01155462 O.13786802 O.13804369 http://www.streetinsider.com/PRNewswire/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html <div class="xn-content"> <p><b>Epitomee's Ingestible Capsule, Offers a Safe and Effective Prescription Solution for Adults with BMI of 25-40 looking for Alternative Drug Free Solutions for Their Weight Management Needs alongside diet and exercise.</b></p> <p><span class="legendSpanClass"><location value="LU/il..caerea" idsrc="xmltag.org" >CAESAREA, Israel</location></span>, <span class="legendSpanClass"><chron>Sept. 16, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://epitomeemedical.com/" target="_blank" rel="nofollow"><span value="TelAviv:EPIT" idsrc="xmltag.org" >Epitomee Medical Ltd.</span></a> (TASE: EPIT), announced that the <span>United States Food and Drug Administration</span> (FDA) has officially cleared the Epitomee® Capsule, a cutting-edge ingestible medical device designed to support weight management in adults with a Body Mass Index (BMI) of 25–40 kg/m² alongside diet and exercise. This novel, drug-free treatment http://www.streetinsider.com/PRNewswire/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html Mon, 16 Sep 2024 11:01:00 -0400 A.31792002 A.36719721 ELOS EPIT O.01155462 O.13786802 O.13804369 http://www.streetinsider.com/PRNewswire/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html <div class="xn-content"> <p><b>Epitomee's Ingestible Capsule, Offers a Safe and Effective Prescription Solution for Adults with BMI of 25-40 looking for Alternative Drug Free Solutions for Their Weight Management Needs alongside diet and exercise.</b></p> <p><span class="legendSpanClass"><location value="LU/il..caerea" idsrc="xmltag.org" >CAESAREA, Israel</location></span>, <span class="legendSpanClass"><chron>Sept. 16, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://epitomeemedical.com/" target="_blank" rel="nofollow"><span value="TelAviv:EPIT" idsrc="xmltag.org" >Epitomee Medical Ltd.</span></a> (TASE: EPIT), announced that the <span>United States Food and Drug Administration</span> (FDA) has officially cleared the Epitomee® Capsule, a cutting-edge ingestible medical device designed to support weight management in adults with a Body Mass Index (BMI) of 25–40 kg/m² alongside diet and exercise. This novel, drug-free treatment http://www.streetinsider.com/PRNewswire/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html Mon, 16 Sep 2024 11:01:00 -0400 A.31792002 A.36719721 ELOS EPIT O.01155462 O.13786802 O.13804369 http://www.streetinsider.com/PRNewswire/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html <div class="xn-content"> <p><b>Epitomee's Ingestible Capsule, Offers a Safe and Effective Prescription Solution for Adults with BMI of 25-40 looking for Alternative Drug Free Solutions for Their Weight Management Needs alongside diet and exercise.</b></p> <p><span class="legendSpanClass"><location value="LU/il..caerea" idsrc="xmltag.org" >CAESAREA, Israel</location></span>, <span class="legendSpanClass"><chron>Sept. 16, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://epitomeemedical.com/" target="_blank" rel="nofollow"><span value="TelAviv:EPIT" idsrc="xmltag.org" >Epitomee Medical Ltd.</span></a> (TASE: EPIT), announced that the <span>United States Food and Drug Administration</span> (FDA) has officially cleared the Epitomee® Capsule, a cutting-edge ingestible medical device designed to support weight management in adults with a Body Mass Index (BMI) of 25–40 kg/m² alongside diet and exercise. This novel, drug-free treatment http://www.streetinsider.com/PRNewswire/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html Mon, 16 Sep 2024 11:01:00 -0400 A.31792002 A.36719721 ELOS EPIT O.01155462 O.13786802 O.13804369 http://www.streetinsider.com/PRNewswire/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html <div class="xn-content"> <p><b>Epitomee's Ingestible Capsule, Offers a Safe and Effective Prescription Solution for Adults with BMI of 25-40 looking for Alternative Drug Free Solutions for Their Weight Management Needs alongside diet and exercise.</b></p> <p><span class="legendSpanClass"><location value="LU/il..caerea" idsrc="xmltag.org" >CAESAREA, Israel</location></span>, <span class="legendSpanClass"><chron>Sept. 16, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://epitomeemedical.com/" target="_blank" rel="nofollow"><span value="TelAviv:EPIT" idsrc="xmltag.org" >Epitomee Medical Ltd.</span></a> (TASE: EPIT), announced that the <span>United States Food and Drug Administration</span> (FDA) has officially cleared the Epitomee® Capsule, a cutting-edge ingestible medical device designed to support weight management in adults with a Body Mass Index (BMI) of 25–40 kg/m² alongside diet and exercise. This novel, drug-free treatment http://www.streetinsider.com/PRNewswire/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html Mon, 16 Sep 2024 11:01:00 -0400 A.31792002 A.36719721 ELOS EPIT O.01155462 O.13786802 O.13804369 http://www.streetinsider.com/PRNewswire/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html <div class="xn-content"> <p><b>Epitomee's Ingestible Capsule, Offers a Safe and Effective Prescription Solution for Adults with BMI of 25-40 looking for Alternative Drug Free Solutions for Their Weight Management Needs alongside diet and exercise.</b></p> <p><span class="legendSpanClass"><location value="LU/il..caerea" idsrc="xmltag.org" >CAESAREA, Israel</location></span>, <span class="legendSpanClass"><chron>Sept. 16, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://epitomeemedical.com/" target="_blank" rel="nofollow"><span value="TelAviv:EPIT" idsrc="xmltag.org" >Epitomee Medical Ltd.</span></a> (TASE: EPIT), announced that the <span>United States Food and Drug Administration</span> (FDA) has officially cleared the Epitomee® Capsule, a cutting-edge ingestible medical device designed to support weight management in adults with a Body Mass Index (BMI) of 25–40 kg/m² alongside diet and exercise. This novel, drug-free treatment http://www.streetinsider.com/PRNewswire/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html Mon, 16 Sep 2024 11:01:00 -0400 A.31792002 A.36719721 ELOS EPIT O.01155462 O.13786802 O.13804369 http://www.streetinsider.com/PRNewswire/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html <div class="xn-content"> <p><b>Epitomee's Ingestible Capsule, Offers a Safe and Effective Prescription Solution for Adults with BMI of 25-40 looking for Alternative Drug Free Solutions for Their Weight Management Needs alongside diet and exercise.</b></p> <p><span class="legendSpanClass"><location value="LU/il..caerea" idsrc="xmltag.org" >CAESAREA, Israel</location></span>, <span class="legendSpanClass"><chron>Sept. 16, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://epitomeemedical.com/" target="_blank" rel="nofollow"><span value="TelAviv:EPIT" idsrc="xmltag.org" >Epitomee Medical Ltd.</span></a> (TASE: EPIT), announced that the <span>United States Food and Drug Administration</span> (FDA) has officially cleared the Epitomee® Capsule, a cutting-edge ingestible medical device designed to support weight management in adults with a Body Mass Index (BMI) of 25–40 kg/m² alongside diet and exercise. This novel, drug-free treatment http://www.streetinsider.com/PRNewswire/Epitomee+Medical+Announces+FDA+Clearance+of+its+Capsule%2C+Weight+Management+Device/23725910.html Mon, 16 Sep 2024 11:01:00 -0400 A.31792002 A.36719721 ELOS EPIT O.01155462 O.13786802 O.13804369